Clinical Trials Directory

Trials / Unknown

UnknownNCT05079737

Sample Collection Study to Assess Prevalence of Gene Mutations: Establishing Population Norms

A Sample Collection Study to Assess the Prevalence of Gene Mutations Associated With Photoaging in Facial Skin From Adults: Establishing Population Norms

Status
Unknown
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
DermTech · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

This is a multi-center, sample collection study to quantitatively assess the presence of gene mutations in subject's skin collected non-invasively. Subjects who consult with a dermatologist or other clinicians will be approached for participation in the study. Once IRB approved informed consent is obtain, subject demographic information, history of sun exposure and samples will be collected.

Detailed description

This is a multi-center, sample collection study to quantitatively assess the presence of gene mutations in subject's skin collected non-invasively. Subjects who consult with a dermatologist or other clinicians will be approached for participation in the study. Once confirmation of participation is confirmed subjects will undergo the informed consent process. Once consented the subject will have their medical history reviewed, concomitant medications and demographic information recorded, complete a sun-exposure questionnaire, have photoaging characteristics (such as melasma, wrinkles, AK lesion(s)) recorded, record their assessment of photoaging, have skin samples collected non-invasively and complete the local skin reaction and local tolerability assessments. A select number of subjects will also have a facial photograph taken. If the location to be sampled contains a lesion, then the collection should occur as close as possible to the target area. The site staff and/or subject will be responsible for collecting the skin samples.

Conditions

Interventions

TypeNameDescription
OTHERMutation BurdenSubjects will have their facial samples analyzed for DNA mutation burden.

Timeline

Start date
2021-02-12
Primary completion
2022-06-15
Completion
2022-09-15
First posted
2021-10-15
Last updated
2021-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05079737. Inclusion in this directory is not an endorsement.